G
Genetalks
Genetic health solutions and bioinformatics computing acceleration
About Genetalks
Genetalks, also known as Renhe Weilai, is a Chinese biotechnology company founded in 2014. The company is headquartered in Changsha, Hunan. Genetalks focuses on providing genetic health solutions based on genetic science.
The company's services include cancer liquid biopsies, building gene data for healthy populations, and biocomputing acceleration. They have launched several professional detection projects in areas such as tumor liquid biopsy, non-invasive prenatal testing, intestinal microbes, and susceptibility genes. Additionally, Genetalks has developed a next-generation bioinformatics computing platform that utilizes an FPGA bioinformatics computing acceleration chip and offers text-based information analysis cloud services. The company primarily operates on a B2B model.
Since its founding, Genetalks has secured funding, including an Early Stage VC (Series A) round on December 26, 2017, for $37.8 million.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- Wangcheng District, China
- Sector
- Health
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- HCHiyield Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genetalks on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genetalks on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.